Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate and Atorvastatin in Variant Angina
NCT01674686Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- Aug 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate, atorvastatin in variant angina, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
sarpogrelateatorvastatin
03
Conditions
variant angina
Beyond the preview
Go deeper on NCT01674686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674686.